Fig. 11

Heatmap of the five targets in patients in the low- and high-risk groups and prognostic validation of the core targets in the NSCLC cohort
Heatmap of the five targets in patients in the low- and high-risk groups and prognostic validation of the core targets in the NSCLC cohort